Latest News
Feature
Science advocates take to D.C. streets in March for Science
WASHINGTON – Doctors, scientists, and advocates came together to demonstarte against the Trump administration’s proposed cuts to science agencies...
Conference Coverage
Sepsis survivors may have high risk for seizures
BOSTON – Survivors of sepsis face a significantly increased risk of seizures following an index hospitalization, regardless of any previous...
Video
VIDEO: Geeks brave rain to March for Science
WASHINGTON – Peaceful demostrators in hundreds of cities around the globe gathered on Earth Day, April 22, to back evidence-based policies and...
Conference Coverage
Monotherapy as good as combo for antibiotic-resistant infections in low-risk patients
Reserve combination therapy for patients with high mortality risk
Conference Coverage
Plazomicin beats gold standard antibiotics in complex, gram-negative bacterial infections
Enterobacteriaceae.
From the Journals
EHR price alert doesn’t reduce lab orders
There are better ways to meet the goals of price transparency.
From the Journals
HIV demographics shifting in U.S.
The number of people living with diagnosed HIV in the United States will increase to 1,232,054 by 2045, up from 917,294 in 2013, according to...
Conference Coverage
Pharmacist-run PrEP clinic proves effective, profitable
SEATTLE – A unique pharmacy-based clinic delivered HIV pre-exposure prophylaxis to vulnerable men who have sex with men, usually on the same day...
Feature
As some holdout states revisit Medicaid expansion, new data show it pays off
Although the GOP-controlled Congress is pledging its continued interest – despite stalls and snags – in dismantling Obamacare, some “red state”...
From the Journals
HIV research update: March 2017
People living with HIV have a higher incidence of non AIDS-defining cancer than the general population, according to a recent study. Read about...
Conference Coverage
Statins in HIV-positive patients are a missed opportunity
WASHINGTON – Despite high cardiovascular risk, just one-quarter of HIV-infected U.S. adults are on a statin.